Literature DB >> 34320167

NAD+ metabolism and cardiometabolic health: the human evidence.

Mahmoud Abdellatif1,2,3, Joseph A Baur4.   

Abstract

Entities:  

Keywords:  Ageing; Cardiovascular disease; Diabetes; NMN; NR; Niacin; Nicotinamide; Obesity

Mesh：

Substances：

Year:  2021        PMID： 34320167      PMCID： PMC8318105          DOI： 10.1093/cvr/cvab212

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   13.081


× No keyword cloud information.
  13 in total

1.  Quantitative Analysis of NAD Synthesis-Breakdown Fluxes.

Authors:  Ling Liu; Xiaoyang Su; William J Quinn; Sheng Hui; Kristin Krukenberg; David W Frederick; Philip Redpath; Le Zhan; Karthikeyani Chellappa; Eileen White; Marie Migaud; Timothy J Mitchison; Joseph A Baur; Joshua D Rabinowitz
Journal:  Cell Metab       Date:  2018-05-01       Impact factor: 27.287

Review 2.  NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR.

Authors:  Jun Yoshino; Joseph A Baur; Shin-Ichiro Imai
Journal:  Cell Metab       Date:  2017-12-14       Impact factor: 27.287

3.  Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure.

Authors:  Bo Zhou; Dennis Ding-Hwa Wang; Yanhua Qiu; Sophia Airhart; Yaxin Liu; April Stempien-Otero; Kevin D O'Brien; Rong Tian
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

4.  A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects.

Authors:  Ole L Dollerup; Britt Christensen; Mads Svart; Mark S Schmidt; Karolina Sulek; Steffen Ringgaard; Hans Stødkilde-Jørgensen; Niels Møller; Charles Brenner; Jonas T Treebak; Niels Jessen
Journal:  Am J Clin Nutr       Date:  2018-08-01       Impact factor: 7.045

5.  Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.

Authors:  Mihoko Yoshino; Jun Yoshino; Brandon D Kayser; Gary J Patti; Michael P Franczyk; Kathryn F Mills; Miriam Sindelar; Terri Pietka; Bruce W Patterson; Shin-Ichiro Imai; Samuel Klein
Journal:  Science       Date:  2021-04-22       Impact factor: 47.728

Review 6.  Caloric restriction mimetics for the treatment of cardiovascular diseases.

Authors:  Sebastiano Sciarretta; Maurizio Forte; Francesca Castoldi; Giacomo Frati; Francesco Versaci; Junichi Sadoshima; Guido Kroemer; Maria Chiara Maiuri
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

7.  NAD+ Repletion Reverses Heart Failure With Preserved Ejection Fraction.

Authors:  Dan Tong; Gabriele G Schiattarella; Nan Jiang; Francisco Altamirano; Pamela A Szweda; Abdallah Elnwasany; Dong I Lee; Heesoo Yoo; David A Kass; Luke I Szweda; Sergio Lavandero; Eric Verdin; Thomas G Gillette; Joseph A Hill
Journal:  Circ Res       Date:  2021-04-22       Impact factor: 23.213

8.  Nicotinamide for the treatment of heart failure with preserved ejection fraction.

Authors:  Mahmoud Abdellatif; Viktoria Trummer-Herbst; Franziska Koser; Sylvère Durand; Rui Adão; Francisco Vasques-Nóvoa; Johanna K Freundt; Julia Voglhuber; Maria-Rosaria Pricolo; Michael Kasa; Clara Türk; Fanny Aprahamian; Elías Herrero-Galán; Sebastian J Hofer; Tobias Pendl; Lavinia Rech; Julia Kargl; Nathaly Anto-Michel; Senka Ljubojevic-Holzer; Julia Schipke; Christina Brandenberger; Martina Auer; Renate Schreiber; Chintan N Koyani; Akos Heinemann; Andreas Zirlik; Albrecht Schmidt; Dirk von Lewinski; Daniel Scherr; Peter P Rainer; Julia von Maltzahn; Christian Mühlfeld; Marcus Krüger; Saša Frank; Frank Madeo; Tobias Eisenberg; Andreas Prokesch; Adelino F Leite-Moreira; André P Lourenço; Jorge Alegre-Cebollada; Stefan Kiechl; Wolfgang A Linke; Guido Kroemer; Simon Sedej
Journal:  Sci Transl Med       Date:  2021-02-10       Impact factor: 19.319

9.  De novo NAD+ biosynthetic impairment in acute kidney injury in humans.

Authors:  Ali Poyan Mehr; Mei T Tran; Kenneth M Ralto; David E Leaf; Vaughan Washco; Joseph Messmer; Adam Lerner; Ajay Kher; Steven H Kim; Charbel C Khoury; Shoshana J Herzig; Mary E Trovato; Noemie Simon-Tillaux; Matthew R Lynch; Ravi I Thadhani; Clary B Clish; Kamal R Khabbaz; Eugene P Rhee; Sushrut S Waikar; Anders H Berg; Samir M Parikh
Journal:  Nat Med       Date:  2018-08-20       Impact factor: 53.440

10.  Niacin protects against abdominal aortic aneurysm formation via GPR109A independent mechanisms: role of NAD+/nicotinamide.

Authors:  Tetsuo Horimatsu; Andra L Blomkalns; Mourad Ogbi; Mary Moses; David Kim; Sagar Patel; Nicole Gilreath; Lauren Reid; Tyler W Benson; Jonathan Pye; Samah Ahmadieh; Allie Thompson; Nathan Robbins; Adrien Mann; Ashlee Edgell; Stephanie Benjamin; Brian K Stansfield; Yuqing Huo; David J Fulton; Gautam Agarwal; Nagendra Singh; Stefan Offermanns; Neal L Weintraub; Ha Won Kim
Journal:  Cardiovasc Res       Date:  2020-12-01       Impact factor: 10.787
View more
  2 in total

Review 1.  NAD+ and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities.

Authors:  Mahmoud Abdellatif; Heiko Bugger; Guido Kroemer; Simon Sedej
Journal:  J Lipid Atheroscler       Date:  2022-04-06

Review 2.  NAD+-Increasing Strategies to Improve Cardiometabolic Health?

Authors:  Francisco Blanco-Vaca; Noemi Rotllan; Marina Canyelles; Didac Mauricio; Joan Carles Escolà-Gil; Josep Julve
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-31       Impact factor: 5.555
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.